Mereo BioPharma Group plc ( MREO) - Stock Earnings
MREO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026, midnight | — / — | — | — / — | — |
MREO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -7.4 million USD | — USD |
| 2026Q1 | -6.7 million USD | — USD |
| 2026Q2 | -7.0 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
MREO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.5 million USD | 10.0 million USD |
| 2024 | -43.3 million USD | — USD |
| 2025 | -41.9 million USD | 500000 USD |
| 2026 Est. | — | — |
MREO
Price: $0.32
52 week price:
Earnings Per Share: -0.19 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 278100
Market Capitalization: 48.3 million